TriSalus Life Sciences Net Income
| TLSI Stock | 5.06 0.32 5.95% |
As of the 28th of February, TriSalus Life has the Semi Deviation of 4.46, coefficient of variation of 4244.47, and Risk Adjusted Performance of 0.0265. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of TriSalus Life Sciences, as well as the relationship between them.
TriSalus Life Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.9638 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -27 M | -28.4 M | |
| Net Loss | -27 M | -28.4 M | |
| Net Loss | (1.44) | (1.51) | |
| Net Income Per E B T | 1.27 | 1.21 |
TriSalus | Net Income | Build AI portfolio with TriSalus Stock |
The Net Income trend for TriSalus Life Sciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether TriSalus Life is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest TriSalus Life's Net Income Growth Pattern
Below is the plot of the Net Income of TriSalus Life Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in TriSalus Life Sciences financial statement analysis. It represents the amount of money remaining after all of TriSalus Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is TriSalus Life's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (30.05 M) | 10 Years Trend |
|
Net Income |
| Timeline |
TriSalus Net Income Regression Statistics
| Arithmetic Mean | (32,190,464) | |
| Coefficient Of Variation | (25.81) | |
| Mean Deviation | 5,083,719 | |
| Median | (28,845,000) | |
| Standard Deviation | 8,308,331 | |
| Sample Variance | 69T | |
| Range | 30.5M | |
| R-Value | (0.42) | |
| Mean Square Error | 60.8T | |
| R-Squared | 0.17 | |
| Significance | 0.1 | |
| Slope | (686,815) | |
| Total Sum of Squares | 1104.5T |
TriSalus Net Income History
Other Fundumenentals of TriSalus Life Sciences
TriSalus Life Net Income component correlations
TriSalus Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for TriSalus Life is extremely important. It helps to project a fair market value of TriSalus Stock properly, considering its historical fundamentals such as Net Income. Since TriSalus Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TriSalus Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TriSalus Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will TriSalus introduce new products? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
Investors evaluate TriSalus Life Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating TriSalus Life's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause TriSalus Life's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, TriSalus Life's market price signifies the transaction level at which participants voluntarily complete trades.
TriSalus Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TriSalus Life's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TriSalus Life.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in TriSalus Life on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding TriSalus Life Sciences or generate 0.0% return on investment in TriSalus Life over 90 days. TriSalus Life is related to or competes with Profound Medical, MaxCyte, Perspective Therapeutics, Anteris Technologies, Prenetics Global, LENSAR, and Nano X. TriSalus Life is entity of United States More
TriSalus Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TriSalus Life's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TriSalus Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.62 | |||
| Information Ratio | 0.0055 | |||
| Maximum Drawdown | 26.66 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 6.61 |
TriSalus Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TriSalus Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TriSalus Life's standard deviation. In reality, there are many statistical measures that can use TriSalus Life historical prices to predict the future TriSalus Life's volatility.| Risk Adjusted Performance | 0.0265 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.006 | |||
| Treynor Ratio | 0.0506 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TriSalus Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TriSalus Life February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0265 | |||
| Market Risk Adjusted Performance | 0.0606 | |||
| Mean Deviation | 3.53 | |||
| Semi Deviation | 4.46 | |||
| Downside Deviation | 4.62 | |||
| Coefficient Of Variation | 4244.47 | |||
| Standard Deviation | 4.99 | |||
| Variance | 24.86 | |||
| Information Ratio | 0.0055 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.006 | |||
| Treynor Ratio | 0.0506 | |||
| Maximum Drawdown | 26.66 | |||
| Value At Risk | (7.86) | |||
| Potential Upside | 6.61 | |||
| Downside Variance | 21.3 | |||
| Semi Variance | 19.93 | |||
| Expected Short fall | (3.88) | |||
| Skewness | 0.6308 | |||
| Kurtosis | 2.51 |
TriSalus Life Sciences Backtested Returns
TriSalus Life Sciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0919, which indicates the firm had a -0.0919 % return per unit of risk over the last 3 months. TriSalus Life Sciences exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TriSalus Life's Coefficient Of Variation of 4244.47, semi deviation of 4.46, and Risk Adjusted Performance of 0.0265 to confirm the risk estimate we provide. The entity has a beta of 2.12, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TriSalus Life will likely underperform. At this point, TriSalus Life Sciences has a negative expected return of -0.43%. Please make sure to validate TriSalus Life's semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if TriSalus Life Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
TriSalus Life Sciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between TriSalus Life time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TriSalus Life Sciences price movement. The serial correlation of -0.14 indicates that less than 14.0% of current TriSalus Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.15 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, TriSalus Life Sciences reported net income of (30.05 Million). This is 108.8% lower than that of the Health Care Equipment & Supplies sector and 112.62% lower than that of the Health Care industry. The net income for all United States stocks is 105.26% higher than that of the company.
TriSalus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TriSalus Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TriSalus Life could also be used in its relative valuation, which is a method of valuing TriSalus Life by comparing valuation metrics of similar companies.TriSalus Life is currently under evaluation in net income category among its peers.
TriSalus Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, TriSalus Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to TriSalus Life's managers, analysts, and investors.Environmental | Governance | Social |
TriSalus Fundamentals
| Return On Equity | -4.96 | ||||
| Return On Asset | -0.61 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (0.78) % | ||||
| Current Valuation | 280 M | ||||
| Shares Outstanding | 49.96 M | ||||
| Shares Owned By Insiders | 35.42 % | ||||
| Shares Owned By Institutions | 19.51 % | ||||
| Number Of Shares Shorted | 1.16 M | ||||
| Price To Book | 30.29 X | ||||
| Price To Sales | 6.29 X | ||||
| Revenue | 29.43 M | ||||
| Gross Profit | 33.79 M | ||||
| EBITDA | (36.16 M) | ||||
| Net Income | (30.05 M) | ||||
| Total Debt | 23.63 M | ||||
| Book Value Per Share | (0.54) X | ||||
| Cash Flow From Operations | (40.84 M) | ||||
| Short Ratio | 9.16 X | ||||
| Earnings Per Share | (2.12) X | ||||
| Target Price | 11.5 | ||||
| Number Of Employees | 110 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 252.82 M | ||||
| Total Asset | 23.97 M | ||||
| Retained Earnings | (279.55 M) | ||||
| Working Capital | 10.44 M | ||||
| Net Asset | 23.97 M |
About TriSalus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TriSalus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TriSalus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TriSalus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is there potential for Health Care Equipment & Supplies market expansion? Will TriSalus introduce new products? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth 0.574 | Return On Assets | Return On Equity |
Investors evaluate TriSalus Life Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating TriSalus Life's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause TriSalus Life's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, TriSalus Life's market price signifies the transaction level at which participants voluntarily complete trades.